Percutaneous Closure of Left Atrial Appendage significantly affects Lipidome Metabolism

Patients with non-valvular atrial fibrillation (AF) and a high risk for oral anticoagulation can be treated by percutaneous implantation of left atrial appendage occlusion devices (LAAC) to reduce the risk of cardio-embolic stroke. This study evaluates whether LAAC may influence lipid metabolism, wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yücel, G., Behnes, M., Barth, C., Wenke, A., Sartorius, B., Mashayekhi, K., Yazdani, B., Bertsch, T., Rusnak, J., Saleh, A., Hoffmann, U., Fastner, C., Lang, S., Zhou, X., Sattler, K., Borggrefe, M., Akin, I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897373/
https://www.ncbi.nlm.nih.gov/pubmed/29650978
http://dx.doi.org/10.1038/s41598-018-23935-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5897373/
https://www.ncbi.nlm.nih.gov/pubmed/29650978
http://dx.doi.org/10.1038/s41598-018-23935-w

Ejemplares similares